FDA Inspection
Baptist Health LexingtonBaptist Health Lexington – FDA Inspection, Apr 7, 2016
Record Details
This FDA Inspection record concerns Baptist Health Lexington, with an inspection on April 7, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Baptist Health Lexington
- Inspection Date
- April 7, 2016
- Product Type
- Biologics
View Company Profile
ID · 119f1da4-41aa-42cb-857c-88c953554dfa
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 965022
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Baptist Health Lexington
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 29, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 8, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 17, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Baptist Health Lexington
- FDA Inspection 876369 - 2014-04-29
- FDA Inspection 771344 - 2012-03-08
- FDA Inspection 646606 - 2010-02-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.